On the other hand, miRNA-140 acts as a tumor suppressor by inhibiting CSCs signaling and cancer initiation through its interaction with SOX2 and SOX9 in both ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). Here, SOX9 is linked to ductal breast carcinoma in situ.